Tag Archives: XBI

Top Medical Stocks For 2018

President and CEO of Varian Medical Systems Inc (NYSE:VAR) Dow R Wilson sold 88,766 shares of VAR on 12/18/2017 at an average price of $111 a share. The total sale was $9.9 million.

Varian Medical Systems Inc is engaged in the healthcare sector. It manufactures medical devices for conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Varian Medical Systems Inc has a market cap of $10.15 billion; its shares were traded at around $110.78 with a P/E ratio of 41.17 and P/S ratio of 3.65. Varian Medical Systems Inc had annual average EBITDA growth of 4.60% over the past ten years.

CEO Recent Trades:

President and CEO Dow R Wilson sold 88,766 shares of VAR stock on 12/18/2017 at the average price of $111. The price of the stock has decreased by 0.2% since.

Directors and Officers Recent Trades:

EVP and Pres. Oncology Sys. Kolleen T Kennedy sold 2,018 shares of VAR stock on 12/13/2017 at the average price of $111.97. The price of the stock has decreased by 1.06% since.

For the complete insider trading history of VAR, click here

Top Medical Stocks For 2018: Sigma Designs, Inc.(SIGM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Sigma Designs Inc (NASDAQ: SIGM) shares dropped 30 percent to $5.43. Sigma Designs reported fiscal third-quarter net income of $221,000 on revenue of $62.7 million.

  • [By Paul Ausick]

    Sigma Designs Inc. (NASDAQ: SIGM) dropped about 34% on Wednesday to post a new 52-week low of $5.20 against a 52-week high of $8.60 and a Tuesday close of $7.75. Volume of about 6.2 million was about 25 times the daily average of around 280,000. The company reported so-so earnings on Tuesday and the stock was downgraded and price targets lowered by several analysts.

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Top Medical Stocks For 2018: Banco Santander, S.A.(SAN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Banco Santander (SAN) : “I prefer Barclays (BCS) , but let’s wait and see what the other banks have to say”

    ProLogis (PLD) : “I am not a fan of that group right now, but that one is best of breed.”

Top Medical Stocks For 2018: Matador Resources Company(MTDR)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Our peer group is up an average of 46% over the past 4 weeks in response to a 30% rebound in the 12-month strip NYMEX oil price. Some of the largest gainers include Hold and Sell rated stocks that we would not chase such asDenbury Resources (Sell, +138%), Halcon Resources (HK) (Sell, +147%), Jones Energy (JONE) (Hold, +166%), Rex Energy (REXX) (Sell, +60%), Sanchez Energy (SN) (Hold, +93%), Ultra Petroleum (UPL) (Sell, +61%), andWhiting Petroleum (Hold, +103%), which have outperformed the E&P Index (+32%) over the same time period. Balance sheets and/or well level returns remain challenged for these companies despite improved oil prices. While we believe oil markets should re-balance over the next 12 to 15 months, the recent recovery to $40 could reverse during 2Q16 as bloated inventories continue to rise, new volumes from Iran pressure an oversupplied market, and a highly anticipated decline in non-OPEC supply (especially in the U.S.), is not as steep as expected. The risk of an oil price retracement, which would significantly pressure the recent out-performers, outweighs the upside in these stocks, in our view. However, we are raising our target prices on Buy ratedAnadarko Petroleum ($54 from $48), Concho Resources (CXO) ($120 from $109), Matador Resources (MTDR) ($22 from $21),Noble Energy (NBL) ($40 from $34), SM Energy (SM) ($22 from $15), Rice Energy ($14 from $12), Pioneer Natural Resources (PXD) ($155 from $135),Continental Resources ($32 from $28), and Parsley Energy (PE) ($24 from $23). We believe our Buy-rated stocks are better positioned to weather challenging oil markets.

  • [By Ezra Schwarzbaum]

    But despite positioning that would thrash other similar companies, Resolute fought through thanks to significant and efficient productivity in its Delaware Basin assets. Wangler believes the strengthening of previous concern areas will make the company a solid investment.

    Matador Resources Co (NYSE: MTDR), $32 Price Target

    Matador has grown its reserves throughout the commodity cycle, as well as its production and cash flow. Haas also likes the company’s history of identifying and acquiring acreage early and cheaply. Much of the analyst’s positive outlook is derived from Matador’s successful monetization of midstream assets and pattern of reinvestment.

Top Medical Stocks For 2018: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

Top Medical Stocks For 2018: Samsung Electronics Co. Ltd. (SSNLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The company is partnering with Chinese company OXi Technology (in which it also made a strategic investment) for developing fingerprint sensor under glass and in the bezel of smartphones. Its fingerprint sensor business received a boost from the Samsung (OTC:SSNLF) S8 and S8+ design wins (as well as Sharp’s (OTCPK:SHCAF) Aquos R and ZTE ZMax Pro).

  • [By SEEKINGALPHA.COM]

    The rate of change in the semiconductor industry is very rapid as implied by the Moore’s law. Hence, it is a very capital-intensive and research-driven industry. The cost of opening a new fab (semiconductor fabrication plant) would cost billions of dollars and roughly 10% of sales for an integrated semiconductor company like Intel (NASDAQ:INTC) and Samsung (OTC:SSNLF) is plowed back into R&D, i.e., billions of dollars annually. Hence, a threat from a new entrant is highly unlikely in the semiconductor industry, at least as of now.

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    According to comments by Universal Display CEO Steve Abramson, Samsung (NASDAQOTH:SSNLF) is pouring $9 billion into building OLED production facilities this year. LG Display (NYSE:LPL) expects more than half of its 2020 revenues to come from OLED panels. The OLED TV market is expected to grow sixfold in the next four years, and the lighting panel market is only just getting started.

  • [By Ashraf Eassa]

    As part of this discussion, he took the time to explain how the technology that Intel calls 14 nanometers is more like what its competitors — Samsung (NASDAQOTH:SSNLF) and Taiwan Semiconductor Manufacturing Co.(NYSE:TSM) — call 10 nanometers (smaller is generally believed to be better).

  • [By Peter Graham]

    A long term performance chart shows shares of mid cap BlackBerry Ltd drifting lower for the past 1 1/2 years whilethe performance of Samsung Electronics (OTCMKTS: SSNLF) and Apple Inc (NASDAQ: AAPL) have beenrising for at least thepast several months:

top stock to invest in

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px ‘Times New Roman’} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px ‘Times New Roman’; min-height: 15.0px} span.s1 {font-kerning: none} span.s2 {text-decoration: underline ; font-kerning: none; color: #0433ff}

President-elect Donald Trump’s economic plan is expected to give a boost to business, which has been pressured by what some consider a tight regulatory environment andhighcorporate taxes. That potential for a rollback in regulation and a corporate tax rate of 15% are reasons the stock market has reacted so positively to Trump’s plans. But what about entrepreneurs and emerging businesses? Will this area still be the growth story it’s been? And where will the jobs andgrowth come from in the coming years?

I caught up with serial entrepreneur Jessica Herrin, CEO and founder of Stella & Dot (and before thatweddingchannel.com back in the 1990’s), who’s created what she calls a modern-day Mary Kay, where she relies on specialists or stylists to get her accessories to customers. Our interview follows, edited for clarity and length.

top stock to invest in: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

top stock to invest in: Constellium N.V.(CSTM)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested that small cap aluminum products and solutions stockConstellium NV (NYSE: CSTM) is looking like a short-term long bullish trade:

  • [By Monica Gerson]

    Constellium NV (NYSE: CSTM) is estimated to report its quarterly earnings at $0.06 per share on revenue of $1.18 billion.

    Qiwi PLC (NASDAQ: QIWI) is expected to report its quarterly earnings at $13.85 per share on revenue of $2.70 billion.

top stock to invest in: California Resources Corporation(CRC)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Friday, the energy sector proved to be a source of strength for the market. Leading the sector was strength from Denbury Resources Inc. (NYSE: DNR) and California Resources Corp (NYSE: CRC).

  • [By Andrew Efimoff]

    WTI crude oil plunged 3.11 percent on Friday to $48.99 a barrel. Below are the biggest energy losers for the day:

    California Resources Corporation (NYSE: CRC): -19.22%
    Dynamic Materials (NASDAQ: BOOM): -12.39%
    Clayton Williams Energy (NYSE: CWEI): -11.45%
    Dynergy (NYSE: DYN): -11.91%
    EP Energy Corporation (NYSE: EPE): -11.20%
    Mexco Energy (NYSE: MXC) -10.90%
    Whiting Petroleum (NYSE: WLL) -10.79%
    Southwestern Energy Company (NYSE: SWN) -10.79%
    SM Energy Company (NYSE: SM) -10.38%
    Real Goods Solar (NASDAQ: RGSE) -10.34%

    Posted-In: Commodities After-Hours Center Markets Movers

  • [By Matthew DiLallo]

    That sell-off in the oil market weighed on financially challenged oil stocks, which will struggle if crude continues dropping. Among the biggest losers were Abraxas Petroleum (NASDAQ:AXAS), Whiting Petroleum (NYSE:WLL), Denbury Resources (NYSE:DNR), California Resources (NYSE:CRC), and Cobalt International Energy (NYSE:CIE).

top stock to invest in: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation peaking in 2014 before falling below the more steady performance of diabetes or insulin stocks like large cap Novo Nordisk A/S (NYSE: NVO) and small cap Insulet Corporation (NASDAQ: PODD):

  • [By Brian Feroldi]

    Shares of Insulet Corporation(NASDAQ:PODD), a medical device company primarily focused on diabetes,rose by as much as 11% in afternoon trading on Friday.

Top 10 Blue Chip Stocks For 2018

On Wednesday, stocks recovered following the worst day overall since October. The gains were led by the technology sector, which in many cases reversed following their worst day of the year on Tuesday.

However, despite the tech rebound, the blue chips lagged pulling the Dow Jones Industrial Average down less than 0.1%. Nike Inc (NYSE:NKE), a Dow component, fell 7.1%, pulled lower by a lackluster outlook for sales growth.

The technology sector of the S&P 500 rose 0.8%, its biggest gain in three weeks. The Nasdaq, which is tech heavy, rose 0.5%, and the 500 jumped chiefly on gains by technology giants Microsoft Corporation (NASDAQ:MSFT), up 1.3%, Apple Inc. (NASDAQ:AAPL), up 1.1%, and Facebook Inc (NASDAQ:FB), up 1.1%. The PHLX Semiconductor Index (NASDAQ:SOXX) did its part by gaining 1.1%.

Crude oil (WTI) fell 0.4% as data showed that stockpiles of crude hit a new record high. Spot WTI closed at $48.04 per barrel for a fall of 11% so far in March.

At the close, the Dow Jones Industrial Average fell 7 points at 20,661, the S&P 500 rose 4 to 2,348, the Nasdaq gained 28 points to close at 5,822, and the Russell 2000 fell a point to 1,346. The NYSE ‘s primary exchange traded 899 million shares with total volume of 3.5 billion shares, and the Nasdaq crossed 1.8 billion shares. On the Big Board, advancers exceeded decliners by 1.1-to-1, and on the Nasdaq, decliners led by 1.3-to-1. Blocks on the NYSE fell to 6,935 from 7,804 on Tuesday.

Top 10 Blue Chip Stocks For 2018: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Chris Lange]

    Look for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) second-quarter results on Thursday. The consensus earnings estimate is $1.07 per share, on $5.73 billion in revenue. The shares were last seen at $32.34. The consensus price target is $36.91, and the 52-week trading range is $27.60 to $55.79.

  • [By Dan Caplinger]

    Momenta Pharmaceuticals soared 25% after the biotechnology company won a lawsuit over alleged patent infringement. A Delaware federal district court found that four patents held by Teva Pharmaceutical (NYSE:TEVA) were invalid, opening the door for Momenta to offer its own competing version of a key drug. Momenta CEO Craig Wheeler provided details in his praise of the decision, noting that it “further bolsters our confidence in the potential for us to offer multiple sclerosis patients a more affordable generic version of Copaxone 40 mg following regulatory approval.” Momenta still has to get past some additional hurdles, but investors are hopeful that the path forward is clearer.

  • [By WWW.MONEYSHOW.COM]

    Opioid drug abuse has become a national epidemic; Teva Pharmaceutical Industries Limited (TEVA) has just developed a drug that could potentially deliver pain relief without the scourge of addiction, suggests Jimmy Mengel, editor of The Crow’s Nest.

Top 10 Blue Chip Stocks For 2018: Tenneco Inc.(TEN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of auto-part makers like Delphi Automotive (DLPH), BorgWarner (BWA), and Tenneco (TEN) are getting killed today, ostensibly due to an article in Automotive News. Wells Fargo’s Richard Kwas and team think Tesla Motors (TSLA) and its Model 3 deserve at least some of the blame:

Top 10 Blue Chip Stocks For 2018: Brookfield Renewable Powerr Fund(BEP)

Advisors’ Opinion:

  • [By Federico Zaldua]

    I expect the Brookfield Group of Companies, which is composed of no fewer than 15 publicly traded entities, to be very active acquisitive in the near-term future. Here I focus my attention on three members of the Brookfield Group that are going to be the most active with M&A. While Brookfield Asset Management (BAM) will concentrate its M&A efforts into all geographies and all asset classes, Brookfield Renewable Energy Partners (BEP) and Brookfield Infrastructure Partners (BIP) will concentrate on their respective industries. Let’s see whether you should go long on any of this separate -although related – entities.

    Good Operational Performance

    Brookfield Asset Management, held by Lou Simpson and Ron Baron, counts with a liquidity position of more than $5 billion at the parent and principal subsidiaries along with nearly $10 billion drawable private fund commitments. More importantly, the company has expressed its interest into using this liquidity to make acquisitions. Management clearly stated in its letter to shareholders:

Top 10 Blue Chip Stocks For 2018: Amphenol Corporation(APH)

Advisors’ Opinion:

  • [By Darren Williams] Although the entire cannabis space has quietly taken a hit of their own medicine in recent weeks and gone to sleep, don’t think for one second the entire space isn’t going to light up again soon. That’s just what they do, right? However, knowing who the pretenders are and knowing who the contenders are is really the challenge when it’s comes right down to it.
    First, anyone who claims to be a grower or a seller of cannabis can’t for one second ever make it as a public company right now, or can even legally consider being a public company for that matter, so you can scratch any of those right off your list. At least here in the U.S. anyway, because Canada is already well ahead of the curve having legalized it for medicinal purposes already.
    More importantly, full legalization of marijuana in Canada appears to be on track for July 2018, which will make Canada just the second nation in the world after Uruguay to completely legalize the cultivation, sale and possession of the drug for medical and recreational purposes.
    Regardless, the best time to buy any stocks in a hot growth sector is when either everyone has forgotten about them, or when the overall market landscape has turned bearish, which has yet to happen. However, the former seems to be the case for the cannabis space, despite some very favorable state legislation last Fall.
    For now, as long as you have a license issued by Health Canada, you’re good to go, so there are some stocks trading in Canada already who are well on their way to making some green for investors. Canopy Growth Corporation (TSE: WEED), formerly Tweed Marijuana Inc., is a medical marijuana company based in Smiths Falls, Ontario. Aurora Cannabis Inc. (CVE: ACB), which is engaged in the production and sale of medical cannabis. There’s also Aphria Pharmaceutical Company (TSE: APH), which also is engaged in producing and selling medical marijuana through retail sales and wholesale channels.
    There are many more, but those are just a
  • [By Lee Jackson]

    This is the top pick in the sector and has remained a favorite at RBC for some time.Amphenol Corp. (NYSE: APH) is one of the worlds largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable.

Top 10 Blue Chip Stocks For 2018: Yingli Green Energy Holding Company Limited(YGE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) is expected to post a quarterly loss at $1.48 per share on revenue of $372.30 million.

    Ameren Corp (NYSE: AEE) is estimated to post its quarterly earnings at $0.38 per share on revenue of $1.51 billion.

  • [By Spencer Israel]

    Axiom Capital Managing Director Gordon Johnson upgraded the entire alternative energy sector from Market Underweight to Market Overweight and upgraded SolarCity Corp (NASDAQ: SCTY) from Sell to Hold and Trina Solar Limited (ADR) (NYSE: TSL), Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Sell to Buy.

  • [By Wayne Duggan]

    Despite the potentially positive recent developments for solar investors, Johnson remains extremely bearish on solar stocks. Axiom maintains Sell ratings on the following U.S.-listed names:

    JA Solar Holdings Co. Ltd. (ADR) (NASDAQ: JASO) Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) Solaredge Technologies Inc (NASDAQ: SEDG) Canadian Solar Inc. (NASDAQ: CSIQ)

    Related Link: Politics Here And Abroad: Muted Market Volume Amid Comey’s Testimony And UK’s Election
    _______
    Image Credit: Screengrab from “Trump Makes Statement On Paris Accord” By The White House [Public domain], via Wikimedia Commons

Top 10 Blue Chip Stocks For 2018: iShares MSCI All Peru Capped ETF (EPU)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    ARGT, the lone exchange traded fund dedicated to Argentine equities, is up 19.6 percent year-to-date. That is good for the second-best showing among Latin America single-country ETFs, trailing only the iShares MSCI Capped Peru Index Fund (NYSE: EPU).

  • [By Andrew Efimoff] Related Some Positive Indexing News For A Frontier Markets ETF Why The Frontier Markets ETF Slumped Last Year Status Quo Decisions Would Bode Well For PAK ETF (Seeking Alpha)
    Related EPU Peru ETF Confronts Politics Commodities Call For The Colombia ETF Gra帽a Y Montero May Have Peaked In 2016 (Seeking Alpha) Gainers Pakistan: Global XMSCI Pakistan ETF (NYSE: PAK) is up 5.67 percent after receiving MSCI’s Emerging Markets Index approval. Peru: iShares MSCI All Peru Capped Index Fund(NYSE: EPU) is up 2.15 percent after Kuzynski won Peru’s nail-biting election. Philippines: iShares MSCI Philippines Investable(NYSE: EPHE) is up 2.21 percent after Macquarie Research said President Elect Rodrigo Duterte would lift the Pilipino property market. India: iShares MSCI India ETF (NYSE: INDA) is up 1.96 percent after India’s government relaxed regulation, making it easier for domestic airlines to fly overseas.

    Related Link: Some Positive Indexing News For A Frontier Markets ETF

Top 10 Blue Chip Stocks For 2018: Actinium Pharmaceuticals, Inc.(ATNM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Actinium Pharmaceuticals Inc (NYSE: ATNM) were down 24 percent to $1.29. Actinium priced 8 million shares at $1.25 per share.

    Shineco Inc (NASDAQ: TYHT) was down, falling around 32 percent to $19.50. On Wednesday, Shineco priced IPO at $4.50 per share.

Top 10 Blue Chip Stocks For 2018: PCM, Inc.(PCMI)

Advisors’ Opinion:

  • [By Lisa Levin]

    PCM Inc (NASDAQ: PCMI) was down, falling around 26 percent to $14.63. PCM reported Q2 adjusted earnings of $0.47 per share on sales of $560.1 million.

Top 10 Blue Chip Stocks For 2018: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

Top 10 Blue Chip Stocks For 2018: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top 10 Casino Stocks For 2018

Elliott R. Morss Ph.D. 漏All Rights Reserved

Introduction

Politicians in Massachusetts, New York and Rhode Island have put aside moral and/or addiction concerns over gambling. Instead, they recently asked why all the gambling dollars from their citizens go to the casinos (and governments) in Connecticut and New Jersey. They responded by approving for new gaming facilities in all three states. Below, data on these actions is presented with commentary.

The Current Situation

Table 1 provides gambling revenues and how they have changed since 2007 for northeast US states, with California, Nevada and Macau included as points of reference. The growth in Macau has been truly amazing. And additional facilities continue to be built there. However, as noted in an earlier piece, Japan has just approved a number of new integrated resort casinos. And these can be expected to siphon off some of the gambling from Macau, Singapore, Malaysia and Australia.

Gambling revenues in Nevada, New Jersey, and Connecticut have not recovered from the 2008 global recession caused by the US banking collapse.

Top 10 Casino Stocks For 2018: XTL Biopharmaceuticals Ltd.(XTLB)

Advisors’ Opinion:

  • [By Lisa Levin]

    X T L Biopharmaceuticals Ltd (ADR) (NASDAQ: XTLB) shares dropped 38 percent to $2.21 after the company reported a $2.5 million registered direct offering.

Top 10 Casino Stocks For 2018: Ultra Clean Holdings, Inc.(UCTT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, technology shares fell 0.65 percent. Meanwhile, top losers in the sector included Ultra Clean Holdings Inc (NASDAQ: UCTT), down 4 percent, and Mitek Systems, Inc. (NASDAQ: MITK), down 7 percent.

  • [By Lisa Levin]

    In trading on Friday, technology shares fell 3.59 percent. Meanwhile, top losers in the sector included Ultra Clean Holdings Inc (NASDAQ: UCTT), down 5 percent, and Brooks Automation, Inc (NASDAQ: BRKS), down 10 percent.

Top 10 Casino Stocks For 2018: Apple Inc.(AAPL)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    A week ago, we published a story about a problem surfacing with the Apple Inc. (AAPL) iPhone 6 lineup, especially the iPhone 6 Plus. So-called Touch Disease was rendering Apples first generation of larger smartphone useless and the company had no fix. Now reports say Touch Disease occurrences are surging to the point where it is the single biggest iPhone issue that Apple Stores have to deal with.

  • [By WWW.THESTREET.COM]

    Walmart continues to impress on tech: Along with more retailers dying being a constant this year, so has Walmart (WMT) surprising in a good way with new tech initiatives. On Thursday, Walmart revealed a new app that will allow people to instantly upload their DVDs so they can be streamed on Apple (AAPL) iPhones or Alphabet (GOOGL) devices, as TheStreet first reported. All one has to do is scan the barcode on the DVD’s case, boom. Take that, Netflix (NFLX) and Amazon (AMZN) . 

  • [By Daniel Sparks]

    Apple (NASDAQ:AAPL) stock has seemingly been hitting new highs every week recently. And now the tech giant’s stock has passed $140 and is trading just over $141 this week. With the stock rising 21% in the past three months, it’s a good time to take a look at Apple’s overall business and ponder what’s next for the tech giant.

  • [By Spencer Israel]

    According to TD Ameritrade, 38,600 trades were made during the four-week competition, 77 percent of which were options trades and 41 percent of which were made on a mobile device. The five most commonly traded stocks were Tesla Motors Inc (NASDAQ: TSLA), Apple Inc (NASDAQ: AAPL), Amazon.com Inc (NASDAQ: AMZN), Netflix Inc (NASDAQ: NFLX) and NVIDIA Corporation (NASDAQ: NVDA).

Top 10 Casino Stocks For 2018: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By ]

    Current top ten holdings include Aetna (NYSE: AET), Citigroup (NYSE: C), Phillip Morris (NYSE: PM), and Tyson (NYSE: TSN), among others. The mutual fund is higher by over 19% this year and has more than 90% of its assets dedicated to domestic equities.

  • [By Ben Levisohn]

    So we find ourselves in the position we have for most of this year: positive on the market averages but less confident in what stocks to buy. While banks have clearly been the flavor of the day we have generally avoided those names. Both Citigroup (C) and Bank of America (BAC) are only now hitting six year highs and we have never advocated chasing winners. Meanwhile the staid, safe defensive stocks (value) like P&G (PG), Coke (KO), and Philip Morris (PM) are lagging. The dichotomy might be illustrated by retailers where Best Buy has been roaring while Gap Stores has been tanking…

  • [By Chris Lange]

    Citigroup Inc. (NYSE: C) is scheduled to reveal its first-quarter results on Thursday. The consensus estimates call for $1.24 in earnings per share (EPS), as well as $17.83 in revenue. Shares endedtrading at $59.43 onFriday. The consensus analyst price target is $64.74. The stock has a 52-week trading range of $38.31 to $62.53.

  • [By Matthew Cochrane]

    With this mindset, it is no wonder that PayPal finished 2016 on a wave of deal-making momentum. In the past 12 months, PayPal completed agreements with a number of financial and tech companies including Alibaba Group Holding Ltd (NYSE: BABA), Citigroup Inc (NYSE: C), Facebook Inc (NASDAQ: FB), Mastercard Inc (NYSE: MA), Visa Inc (NYSE: V), and Vodafone Group Plc (NASDAQ: VOD).

Top 10 Casino Stocks For 2018: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).

Top 10 Casino Stocks For 2018: Stage Stores, Inc.(SSI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Stage Stores Inc. (NYSE: SSI) dropped nearly 20% on Monday to post a new 52-week low of $3.21 after closing at $4.00 on Friday. Volume was more than 5 times the daily average of about 650,000 shares. The company posted poor holiday season sales last Friday and lowered its guidance.

  • [By Lisa Levin]

    Stage Stores Inc (NYSE: SSI) was down, falling around 16 percent to $3.35 as the company reported a drop in its holiday season same-store sales and lowered its earnings guidance. The retailer’s same-store sales dropped 7.3 percent for the nine-week period ending December 31, 2016.

Top 10 Casino Stocks For 2018: Kalytera Therapeutics, Inc. (QUEZF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Kalytera Therapeutics Inc (OTC: QUEZF) closed a C$13.4 million ($10.2 million) tranche of a private placement for the acquisition of Talent Biotechs Ltd.

Top 10 Casino Stocks For 2018: Caesars Entertainment Corporation(CZR)

Advisors’ Opinion:

  • [By Travis Hoium]

    Wynn Resorts (NASDAQ:WYNN) and Caesars Entertainment (NASDAQ:CZR) are two of the most well known gaming companies in the world. But they’re very different companies with very different futures ahead.

  • [By AlphaStreetResearch]

    Caesars Entertainment Corporation (CZR) is a highly overvalued gaming, hotel, and entertainment company with deteriorating fundamentals on all levels in a highly competitive environment. The company’s stock has seen a massive run to the upside on the coattails of other casino and entertainment companies in the space. A considerable catalyst for the push higher in these stocks is the good news coming out of Macau, but this is an area where Caesars has absolutely no exposure and will be locked out of for the foreseeable future after failing to take appropriate licensing measures. Below is our introduction into the business model, its weaknesses, and the new selling or shorting opportunity that exists for CZR after the recent appreciation in share price. Investors will soon realize that there is little upside value in this company and that there are much better opportunities in this space. The company is now amidst a major struggle from a debt standpoint with major deadlines approaching over the next year and a half. The company is in no position to thrive going forward unless major steps are taken to overhaul the company’s capital structure. Caesars Entertainment has a market cap of $3.19 Billion after the stock has moved up over 225% year to date and reports its next quarter on October 31, 2013. With this in mind, we value CZR at $21.00 by year-end of 2013 and $14.00 by August 1, 2014, a decrease of 40% from current levels. We will later highlight:

  • [By Michael E. Lewitt]

    Back in April, I recommendedCaesars Entertainment Corp.(Nasdaq: CZR) as a buy – but warned you that this was a play that might take some time to mature.

Top 10 Casino Stocks For 2018: MediWound Ltd.(MDWD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Mediwound Ltd (NASDAQ: MDWD) were down 17 percent to $5.03. Mediwound priced its 4,400,000 offering of ordinary shares at $5 per share.

    Aldeyra Therapeutics Inc (NASDAQ: ALDX) was down, falling around 20 percent to $7.30. Aldeyra Therapeutics reported proposed public offering of common stock.

Top 10 Casino Stocks For 2018: Microsoft Corporation(MSFT)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    Amazon.com Inc. (NSDQ:AMZN)stock fell by more than 5 % over the last week. There were a series of service announcements last week by Amazons cloud-computing business, AWS, but they also didn’t do much to support the falling AMZN stock. However, AWS re:Invent 2016 has reaffirmed that AWS is one strong reason to buy AMZN stock now. AWS is expected to top $12 billion in revenue this year, compared with $7.9 billion last year. The public cloud pioneer has gone from being the largest, most dominant public cloud service for web developers and startups to providing the most important technology to businesses: the enterprise cloud. Amazon has sustained its aggressive cloud approach, even though competitors like Microsoft (NSDQ:MSFT) and Alphabet (NSDQ:GOOGL) are trying to catch up, using their deep pockets. Here’s why AWS is not slowing down anytime soon and will continue to drive AMZN stock to greater heights.

  • [By Wayne Duggan]

    Sogou is Baidu’s biggest rival when it comes to mobile search engine market share. The app is owned by Sohu.com Inc (NASDAQ: SOHU), and its position as second fiddle to Baidu makes it most similar to Microsoft Corporation (NASDAQ: MSFT)’s Bing.

  • [By Chris Neiger]

    And within the machine learning space, three key players have emerged:IBM (NYSE:IBM), Amazon.com (NASDAQ:AMZN), and Microsoft (NASDAQ:MSFT). These companies accounted for a combined 73% of the machine learning market last year, according to Transparency Market Research, so let’s take a look at what each is doing in the space and how they’re likely to continue dominating.

best stocks of today

Ambarella (NASDAQ:AMBA) is an innovative, up-and-coming technology company whose stock is a rollercoaster that runs on emotions, knee-jerk reactions, and then, sometimes, fundamentals. The trick for any investor other than long-term (think years) is to find out which one will rule price movement next. Before we get to that, some context on my opinion/experience with the stock.

AMBA data by YCharts

After originally covering AMBA during the huge run-up into the $120 range back in late 2015, I wrote a piece in September of 2016 arguing that high expectations leading into Q2 2017 would drop the stock post-earnings, which ended up being the case. That article can be found here. A short time after when the stock was hovering around $68 I wrote another article titled “Ambarella: Be Cautious” in which I argued that the potential short-term risks and headwinds facing the company were not to be taken lightly. That article can be found here.

best stocks of today: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

    American Axle & Manufact. Holdings, Inc. (NYSE: AXL) is expected to report its quarterly earnings at $0.71 per share on revenue of $998.76 million.

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion. CST Brands shares declined 1.20 percent to close at $36.21 on Thursday.

best stocks of today: NO Name(ACI)

Advisors’ Opinion:

  • [By Robert Weinstein]

    Lawsuit after lawsuit, a billion dollars in cost overruns, taxpayer subsidies and the most expensive coal plant to operate causing electric rates to skyrocket, if this becomes the norm. The new project is called Plant Ratcliffe by Southern Co.
    Plant Ratcliffe is quite the boondoggle, but proponents say it always costs more to build the first one and costs will come down as the technology improves. More plants are in the planning stages and may bring a needed shot in the arm to mining stocks.
    Alpha Natural Resources (ANR), Walter Energy (WLT), Arch Coal (ACI), Cliffs Natural Resources (CLF), Peabody Energy (BTU), and James River Coal (JRCC) are companies that may benefit from increased demand for coal.
    Not all coal or coal companies are equal, so it’s crucial to discriminate based on your investment time-horizon goals. With that said, the announcement should have been followed by a deep sell-off in coal and utility related stocks. But something happened.
    Or, rather, didn’t happen.
    The above coal stocks didn’t sell off tremendously and are largely moving along with the rest of the market today. This is noteworthy because stocks don’t bottom on good news, they reach a bottom on awful news. Let me explain: When a stock chart continues trending lower, what you’re witnessing is investors throwing in the towel and moving on.
    Leaving aside bankruptcies for a moment, almost all stocks have a core group of investors that are commonly known as the “strong hands.” A stock is at the bottom when the weak hands are gone. At some point, distressing news (like an unfavorable EPA announcement regarding coal) hits the wire and the related stock or stocks react with little or no movement. This is what we are witnessing right now in coal-related companies.

best stocks of today: Laboratory Corporation of America Holdings(LH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts expect Laboratory Corp. of America Holdings (NYSE: LH) to report its quarterly earnings at $1.96 per share on revenue of $2.19 billion. Laboratory Corp shares rose 0.64 percent to close at $121.77 on Friday.

  • [By Monica Gerson]

    Laboratory Corp. of America Holdings (NYSE: LH) is estimated to report its quarterly earnings at $1.96 per share on revenue of $2.19 billion.

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

best stocks of today: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

best stocks of today: Dow Treasuries(DV)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart of Apollo Education Group along with peersITT Educational Services, Inc (NYSE: ESI) and DeVry Education Group Inc (NYSE: DV) reflect the headwinds from the Obama administration:

best stocks of today: 2U, Inc.(TWOU)

Advisors’ Opinion:

  • [By David Kretzmann]

    Since its IPO in March 2014, 2U (NASDAQ:TWOU) stock is up over 160% as the company forges partnerships with famous schools, including Georgetown, Yale, Berkeley, and New York University.

stock list

What most retirement savers want to know is if they’re saving enough money. Actually, that’s one of the easiest questions to answer because you can plug in your numbers into hundreds of online retirement calculators.

The harder questions have to do with financial wellness. How do your emotions help or hurt your ability to save and invest? Your gut often determines if you’re even ready to retire.

Some investors choose to save more than they spend or may have debts that keep them from socking away money. Others may be saving diligently, but may be too active in managing their money. Many behaviors may short-circuit one’s ability to save.

Professor Harry Markowitz. (AP Photo)

Harry Markowitz, the chief architect for Guided Choice, a retirement advisory firm, knows a few things about investing. As the father of Modern Portfolio Theory, he won the Nobel Prize in Economics for his work on diversified portfolios.

stock list: Territorial Bancorp Inc.(TBNK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Territorial Bancorp (NASDAQ: TBNK) shares touched a new 52-week low of $21.31. Territorial Bancorp shares have dropped 9.43% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.

stock list: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

  • [By ]

    And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).

stock list: Catalyst Pharmaceuticals, Inc.(CPRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) got a boost, shooting up 32 percent to $1.54 after the company reported positive data from investigator-sponsored trial of Firdapse.

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

stock list: Paradise, Inc. (PARF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Paradise Inc. (OTCPK:PARF)

    This company is focused on producing candied fruit, which is the basic ingredient of fruitcakes a dessert popular during Thanksgiving and Christmas in the US. They also produce their own plastic containers for these. While this product might not be wildly popular or its demand increasing, the company has a commanding portion of the market share (as mentioned by the management) and its sales have been stable and the company is able to be profitable.

stock list: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

stock index

What happened

Shares of Snap Inc. (NYSE:SNAP)were up 6.1% as of 3:00 p.m. EDT Thursday after the Snapchat parent became the recipient of yet another (mostly) positive analyst note.

So what

More specifically, Piper Jaffray analyst Samuel Kemp initiated coverage on Snap stock with a neutral rating and a $23-per-share price target — a modest premium from Snap’s closing price of $21.84 on Wednesday. Kemp elaborated that Snap is attractive to advertisers given its “unique communications model that funnels interactions to a narrower number of relationships,” which in turn results in higher-quality content.

IMAGE SOURCE: GETTY IMAGES.

Even so, Kemp warned that Snap’s narrow focus leaves it susceptible to disruption by “copycat competition,” which is why he prefers to watch its progress from the sidelines for now.

stock index: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

stock index: Avanir Pharmaceuticals Inc(AVNR)

Advisors’ Opinion:

  • [By Paul Ausick]

    Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analysts upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.

stock index: Wipro Limited(WIT)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.

stock index: Wells Fargo & Company(WFC)

Advisors’ Opinion:

  • [By Sarfaraz Khan]

    In addition to this, Warren Buffett has also built sizable positions in a number of major US banks.Wells Fargo (NYSE:WFC), U.S. Bancorp (NYSE:USB)and Goldman Sachs (NYSE:GS)have the leading positions in Berkshire Hathaways portfolio. In fact, Wells Fargo is Berkshire Hathaway’s second largest stock holding. In addition to this, Berkshire Hathaway also owns $5 billion worth of Bank of Americas preferred shares and warrants to buy 700 million of the banks ordinary shares at just $7.14 (current price $22.10) anytime until September 2021. These banks are positioned to become the biggest beneficiaries of the increase in interest rates. To get an idea of how this might happen, consider Bank of Americas forecast in which it predicted a $7.5 billion boost to annual net interest income following a 1-percentage-point increase in interest rates.

  • [By Money Morning Staff Reports]

    This jump primarily had to do with Berkshire’s stake in Wells Fargo & Co. (NYSE: WFC), which rose 5.4% on Nov. 9 alone. This spike in the embattled bank’s shares added $1.7 billion to Buffett’s fortune in the span of 24 hours.

  • [By Ben Levisohn]

    Earnings season is getting underway this week, with big banks JPMorgan Chase (JPM), Bank of America (BAC), and Wells Fargo (WFC) announcing their results on Friday. They’ll be followed by Citigroup (C) and Morgan Stanley (MS) on Jan. 17, and Goldman Sachs (GS) on Jan. 18.

investment meaning

Redfin (RDFN), or “Real Estate Redefined” in an abbreviated form, is one of the exciting new unicorn IPOs of 2017. Taking the massive real estate market and flipping it on its head is the goal of RDFN. They are attempting to be a disruptor in the space, and the Q2 2017 results show some great promise going forward. Knowledgeable real estate names like Zillow (ZG) CEO Spencer Rascoff realize RDFN is a large threat to the industry as a whole. By streamlining the home buying process and lowering broker fees, RDFN looks to make buying a home cheaper and easier. Technology is the foundation of the company, and young millennial home buyers aged 25-40 are the target audience. As this generation ages over the next 5-10 years, Redfin can expand with the tech savvy masses. Redfin is poised for some large growth years ahead of it, but the stock price is certainly more of a question mark. While I am impressed by the growth rate and results, the stock sits at quite the lofty valuation. Let’s take a look at the Q2 numbers and see if it is worth its $2.2B valuation at the moment.

investment meaning: Church & Dwight Company, Inc.(CHD)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Remember when companies used to split their stock to keep individual shares affordable? No longer. Credit Suisse strategistsAna Avramovic andVictor Lin note that Church & Dwight (CHD) upcoming stock split will be just the fourth by an S&P 500 stock this year:

  • [By Shauna O’Brien]

    Deutsche Bank announced on Tuesday that it has upgraded Church & Dwight Co., Inc. (CHD).

    The firm has raised its rating on CHD from “Hold” to “Buy,” and has increased the company’s price target from $64 to $66. This price target suggests an 8% upside from the stock’s current price of $60.36.

    Analyst Bill Schmitz commented: “Sustainable growth algorithm of 3-4% organic sales, high single digit EBIT and double-digit EPS growth intact, with upside from fast growing Avid vitamin business joining the base and highly flexible balance sheet enabling further M&A or more aggressive cash flow redeployment providing upside to total shareholder return profile.

    “With shares underperforming the group and market over the last year and tempered Street outlook for CY14 versus long-term trend, we see an opportunistic window to own the shares at a reasonable entry point.”

    Church & Dwight shares were mostly flat during pre-market trading Tuesday. The stock is up 13% YTD.

  • [By Monica Gerson]

    Church & Dwight Co., Inc. (NYSE: CHD) shares rose 7.32 percent to $104.10 in pre-market trading. Negocios.com reported that Reckitt Benckiser will offer $23 billion for Church & Dwight.

investment meaning: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    After sneaking lower to begin the new trading week, the SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels.

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

investment meaning: Computer Sciences Corporation(CSC)

Advisors’ Opinion:

  • [By R. Chandrasekaran]

    Some of the outperforming stocks:

    NVDIA Corp (NASDAQ: NVDA) trading up about 5.7 percent with a range between $69.50 and $71.72.
    Amazon.com, Inc. (NASDAQ: AMZN) is gaining about 4 percent. The stock ranged between $770.94 and $787.73.
    Computer Sciences Corporation (NYSE: CSC) is gaining about 3.3 percent with the stock trading between $56.10 and $58.01.
    Microsoft Corporation (NASDAQ: MSFT) is adding about 3 percent with the stock ranging $59.78-$60.52.
    Alphabet Inc (NASDAQ: GOOGL) is gaining about 2.9 percent with the stock trading between $792.90 and $805.
    Intel Corporation (NASDAQ: INTC) is adding approximately 2.9 percent with shares trading in the range of $34.15-$34.60.
    Cisco Systems, Inc. (NASDAQ: CSCO) is gaining about 2.8 percent as the stock traded between $30.61 and $31.05.
    Salesforce.com, inc. (NYSE: CRM) is adding about 2.8 percent with the shares traded in the range of $75.41-$77.00

  • [By Monica Gerson] Related CSC Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Computer Sciences' (CSC) CEO Mike Lawrie on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Hewlett Packard Enterprise Announces Plans for Tax-Free Spin-Off and Merger of Enterprise … (GuruFocus)

    Some of the stocks that may grab investor focus today are:

investment meaning: Lithium X Energy Corp. (LIXXF)

Advisors’ Opinion:

  • [By Tom Bishop]

    Lithium X Energy NPV (LIXXF) owns 50% of the Sal de los Angeles lithium brine project in the prolific “Lithium Triangle” in mining friendly Salta province, Argentina.

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

investment meaning: McKesson Corporation(MCK)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Drug-distribution specialist McKesson (NYSE:MCK) has had a tough year. Even as the overall stock market has climbed, the company’s shares have suffered, as investors fear that any business related to pharmaceuticals will have a political target on its back even under the current administration. Last quarter’s sluggish numbers didn’t create much enthusiasm for McKesson either.

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Douglas A. McIntyre]

    McKesson Corp. (NYSE: MCK), the leading pharmaceutical distributor, posted a revenue increase in the past year of $49.7 billion, up from $47.5 billion in ayear earlier. Its management offered hefty earnings for the quarter and year ahead. It continues to be a buyer of other companies, most recently Change Healthcare (which was labeled a merger with one of McKesson’s divisions). The current dividend is $1.12, or 0.61%.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 1.77 percent. Meanwhile, top losers in the sector included McKesson Corporation (NYSE: MCK), down 24 percent, and Novo Nordisk A/S (ADR) (NYSE: NVO), down 13 percent.